{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:54:50Z","timestamp":1793199290545,"version":"4.5.0"},"reference-count":232,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005013","name":"Academic Center for Education, Culture and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yexcr.2025.114769","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:47:45Z","timestamp":1758566865000},"page":"114769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular mechanism and the main signaling pathways in the development and progression of multiple sclerosis"],"prefix":"10.1016","volume":"452","author":[{"given":"Leila","family":"Naserpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-0562","authenticated-orcid":false,"given":"Saeedeh Zare","family":"Jalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Khoshandam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-3805","authenticated-orcid":false,"given":"Faezeh","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnen\/nlab083","article-title":"Multiple sclerosis: microglia, monocytes, and macrophage-mediated demyelination","volume":"80","author":"Prineas","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/ern.10.13","article-title":"Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination","volume":"10","author":"Watzlawik","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"issue":"1821","key":"10.1016\/j.yexcr.2025.114769_bib5","article-title":"Progress and promise in understanding the genetic basis of common diseases","volume":"282","author":"Price","year":"2015","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00399","article-title":"How do cells of the oligodendrocyte lineage affect neuronal circuits to influence motor function, memory and mood?","volume":"12","author":"Pepper","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2377-14-107","article-title":"Children and adolescents adjustment to parental multiple sclerosis: a systematic review","volume":"14","author":"Razaz","year":"2014","journal-title":"BMC Neurol."},{"issue":"23","key":"10.1016\/j.yexcr.2025.114769_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114769_bib10","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114769_bib11","article-title":"B cells in central nervous system disease: diversity, locations and pathophysiology","author":"Jain","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","article-title":"Microglia in central nervous system inflammation and multiple sclerosis pathology","volume":"25","author":"Voet","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12031-024-02286-4","article-title":"Role and interplay of different signaling pathways involved in sciatic nerve regeneration","volume":"74","author":"Jalise","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fncel.2018.00399","article-title":"How do cells of the oligodendrocyte lineage affect neuronal circuits to influence motor function, memory and mood?","volume":"12","author":"Pepper","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: myelination and axonal support","volume":"8","author":"Simons","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"13","key":"10.1016\/j.yexcr.2025.114769_bib16","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1113\/JP270895","article-title":"Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury","volume":"594","author":"Alizadeh","year":"2016","journal-title":"J. Physiol."},{"issue":"458","key":"10.1016\/j.yexcr.2025.114769_bib17","article-title":"Strategies for oligodendrocyte and myelin repair in traumatic CNS injury","volume":"14","author":"Huntemer-Silveira","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines10020335","article-title":"Regulatory cells in multiple sclerosis: from blood to brain","volume":"10","author":"Calahorra","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2025.114769_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134980","article-title":"Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination","volume":"729","author":"Gorter","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.yexcr.2025.114769_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-030-19515-1_7","article-title":"Disruption of the blood-brain barrier during neuroinflammatory and neuroinfectious diseases","author":"Salimi","year":"2019","journal-title":"Neuroimmune Dis"},{"issue":"10130","key":"10.1016\/j.yexcr.2025.114769_bib21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"19","key":"10.1016\/j.yexcr.2025.114769_bib23","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1523\/JNEUROSCI.6005-11.2012","article-title":"Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness","volume":"32","author":"Furusho","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1389450121999201012201926","article-title":"Targeting drugs against fibroblast growth factor (s)-Induced cell signaling","volume":"22","author":"Agrawal","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib27","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cells10113242","article-title":"The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration","volume":"10","author":"Farooq","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114769_bib28","series-title":"Seminars in Cell & Developmental Biology","article-title":"Developmental principles informing human pluripotent stem cell differentiation to cartilage and bone","author":"Humphreys","year":"2021"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib29","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1523\/JNEUROSCI.3316-16.2017","article-title":"Signaling by FGF receptor 2, not FGF receptor 1, regulates myelin thickness through activation of ERK1\/2-MAPK, which promotes mTORC1 activity in an akt-independent manner","volume":"37","author":"Furusho","year":"2017","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/cells10040884","article-title":"FGF\/FGFR pathways in multiple sclerosis and in its disease models","volume":"10","author":"Rajendran","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210292","article-title":"Roles of fibroblast growth factors in the axon guidance","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0864-6","article-title":"Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential","volume":"7","author":"Th\u00fcmmler","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s40478-019-0864-6","article-title":"Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential","volume":"7","author":"Th\u00fcmmler","year":"2019","journal-title":"Acta. Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11481-013-9501-5","article-title":"Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration","volume":"9","author":"Woodbury","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"255","key":"10.1016\/j.yexcr.2025.114769_bib35","article-title":"Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression","volume":"12","author":"Tang","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"Pt 7","key":"10.1016\/j.yexcr.2025.114769_bib36","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awv102","article-title":"Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9","volume":"138","author":"Lindner","year":"2015","journal-title":"Brain : J. Neurol."},{"issue":"79","key":"10.1016\/j.yexcr.2025.114769_bib37","article-title":"Astrocytes and microglia as major players of myelin production in normal and pathological conditions","volume":"14","author":"Traiffort","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib38","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awv102","article-title":"Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9","volume":"138","author":"Lindner","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.yexcr.2025.114769_bib39","first-page":"1","article-title":"Fibroblast growth factor signalling in the diseased nervous system","author":"Klimaschewski","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.yexcr.2025.114769_bib40","series-title":"Elucidating the Functions of Fibroblast Growth Factor 9 in Multiple Sclerosis","author":"McElroy","year":"2018"},{"key":"10.1016\/j.yexcr.2025.114769_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2011.10.054","article-title":"Ras\/p38 and PI3K\/Akt but not Mek\/Erk signaling mediate BDNF-induced neurite formation on neonatal cochlear spiral ganglion explants","volume":"1430","author":"Mullen","year":"2012","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.657","article-title":"Regulation of bone homeostasis: signaling pathways and therapeutic targets","volume":"5","author":"Wu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2025.114769_bib43","article-title":"Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies","author":"Liu","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bpa.12487","article-title":"Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK\/AKT phosphorylation","volume":"28","author":"Rajendran","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.yexcr.2025.114769_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0168-9","article-title":"Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination","volume":"2","author":"Mohan","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene therapy-induced antigen-specific Tregs inhibit neuro-inflammationand reverse disease in a mouse model of multiple sclerosis","volume":"26","author":"Keeler","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2025.114769_bib47","series-title":"Concurrent Activation of Regenerative and Tolerogenic Processes by Fibroblast-Based Compositions for the Treatment of Multiple Sclerosis","author":"O'heeron","year":"2024"},{"key":"10.1016\/j.yexcr.2025.114769_bib48","article-title":"Multiple sclerosis treatments a review of current biomedical engineering approaches","author":"Mohseni","year":"2024","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2567.2011.03450.x","article-title":"Neuroprotective role of fibroblast growth factor\u20102 in experimental autoimmune encephalomyelitis","volume":"133","author":"Rottlaender","year":"2011","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.17341","article-title":"Anti\u2010inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis","volume":"182","author":"Gurski","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114769_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0864-6","article-title":"Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential","volume":"7","author":"Th\u00fcmmler","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib52","first-page":"201","article-title":"Fibroblast growth factor-2 levels are elevated in the serum of patients with multiple sclerosis","volume":"19","author":"Jari","year":"2022","journal-title":"Iran. J. Immunol."},{"issue":"23","key":"10.1016\/j.yexcr.2025.114769_bib53","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1111\/bph.16186","article-title":"The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti\u2010inflammatory effects and remyelination in a model of multiple sclerosis","volume":"180","author":"Rajendran","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10020-024-00784-0","article-title":"Involvement of Fgf2-mediated tau protein phosphorylation in cognitive deficits induced by sevoflurane in aged rats","volume":"30","author":"Xie","year":"2024","journal-title":"Mol. Med."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12935","article-title":"Fibroblast growth factor 9 (FGF9)\u2010mediated neurodegeneration: implications for progressive multiple sclerosis?","volume":"49","author":"Th\u00fcmmler","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"40","key":"10.1016\/j.yexcr.2025.114769_bib56","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1523\/JNEUROSCI.1377-20.2021","article-title":"mTOR signaling regulates metabolic function in oligodendrocyte precursor cells and promotes efficient brain remyelination in the cuprizone model","volume":"41","author":"Jeffries","year":"2021","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/0115672026274954230919070115","article-title":"Targeting the AKT\/mTOR\/p70S6K pathway for oligodendrocyte differentiation and myelin regeneration in neurological disorders","volume":"20","author":"Ge","year":"2023","journal-title":"Curr. Neurovascular Res."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12974-019-1590-5","article-title":"Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions","volume":"16","author":"Mu\u00f1oz-San Mart\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00109-021-02080-4","article-title":"Multiple sclerosis is linked to MAPKERK overactivity in microglia","volume":"99","author":"Ten Bosch","year":"2021","journal-title":"J. Mol. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00109-021-02080-4","article-title":"Multiple sclerosis is linked to MAPK(ERK) overactivity in microglia","volume":"99","author":"Ten Bosch","year":"2021","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"269","key":"10.1016\/j.yexcr.2025.114769_bib61","article-title":"Dynamic responses of microglia in animal models of multiple sclerosis","volume":"14","author":"Plastini","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib62","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s12640-021-00401-6","article-title":"Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases","volume":"39","author":"Singh","year":"2021","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib63","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1381612822666161214153108","article-title":"Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies","volume":"23","author":"Bjelobaba","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"19","key":"10.1016\/j.yexcr.2025.114769_bib64","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1007\/s00018-019-03132-2","article-title":"Microglial priming of antigen presentation and adaptive stimulation in Alzheimer's disease","volume":"76","author":"Das","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib65","first-page":"1","article-title":"Multiple sclerosis is linked to MAPK ERK overactivity in microglia","author":"Ten Bosch","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.yexcr.2025.114769_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcell.2016.00056","article-title":"Emerging roles of the mitogen and stress activated kinases MSK1 and MSK2","volume":"4","author":"Reyskens","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00109-021-02080-4","article-title":"Multiple sclerosis is linked to MAPKERK overactivity in microglia","volume":"99","author":"Ten Bosch","year":"2021","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/biom11010099","article-title":"Microglia-mediated neurodegeneration in perinatal brain injuries","volume":"11","author":"Fleiss","year":"2021","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114769_bib69","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4103\/1673-5374.237109","article-title":"Role of nuclear factor \u03baB in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"13","author":"Yue","year":"2018","journal-title":"Neural Regenerat. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2377-14-38","article-title":"Treatment satisfaction, adherence and behavioral assessment in patients de \u2013 escalating from natalizumab to interferon beta","volume":"14","author":"Zecca","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.yexcr.2025.114769_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.549842","article-title":"Natalizumab in multiple sclerosis treatment: from biological effects to immune monitoring","volume":"11","author":"Khoy","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev. : MMBR (Microbiol. Mol. Biol. Rev.)"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib73","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/glia.23606","article-title":"Inhibition of MAPK\/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases","volume":"67","author":"Suo","year":"2019","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114769_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2020.00391","article-title":"Nuclear factor \u03baB (NF-\u03baB)\u2013mediated inflammation in multiple sclerosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114769_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fbioe.2020.00397","article-title":"Investigating the causal effect of brain expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 genes on multiple sclerosis: a two-sample Mendelian randomization approach","volume":"8","author":"Fazia","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib77","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.yexcr.2025.114769_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104918","article-title":"Nuclear factor kappa B in autism spectrum disorder: a systematic review","volume":"159","author":"Liao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexcr.2025.114769_bib80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0074-7742(09)85024-1","article-title":"NF-kappaB dimers in the regulation of neuronal survival","volume":"85","author":"Sarnico","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib81","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s12035-020-02220-w","article-title":"Fibroblast growth factor 9 stimulates neuronal length through NF-kB signaling in striatal cell Huntington's disease models","volume":"58","author":"Yusuf","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"488","key":"10.1016\/j.yexcr.2025.114769_bib82","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"54","key":"10.1016\/j.yexcr.2025.114769_bib83","first-page":"452","article-title":"Paradigm shifts in the role of CD4+ T cells in keratoplasty","volume":"10","author":"Cunnusamy","year":"2010","journal-title":"Discov. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib84","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/jcm9082534","article-title":"Reduced I\u03baB-\u03b1 protein levels in peripheral blood cells of patients with multiple sclerosis-A possible cause of constitutive NF-\u03baB activation","volume":"9","author":"Yan","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","article-title":"Oligodendrocytes: biology and pathology","volume":"119","author":"Bradl","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"391","key":"10.1016\/j.yexcr.2025.114769_bib86","article-title":"Nuclear factor \u03baB (NF-\u03baB)\u2013Mediated inflammation in multiple sclerosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib87","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114769_bib89","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2020.00391","article-title":"Nuclear factor \u03baB (NF-\u03baB)-Mediated inflammation in multiple sclerosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib90","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awt023","article-title":"Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis","volume":"136","author":"Jolivel","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib91","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/antiox9101022","article-title":"Merging the multi-target effects of phytochemicals in neurodegeneration: from oxidative stress to protein aggregation and inflammation","volume":"9","author":"Limanaqi","year":"2020","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib92","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s10067-021-05579-w","article-title":"Modulation of TNFR 1-triggered two opposing signals for inflammation and apoptosis via RIPK 1 disruption by geldanamycin in rheumatoid arthritis","volume":"40","author":"Saeki","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"26","key":"10.1016\/j.yexcr.2025.114769_bib93","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1806973115","article-title":"Regulation of a distinct activated RIPK1 intermediate bridging complexI and complex II in TNF\u03b1-mediated apoptosis","volume":"115","author":"Amin","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib94","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib95","doi-asserted-by":"crossref","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"Isra\u00ebl","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib96","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M114.593426","article-title":"A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling","volume":"290","author":"Nilsen","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/jir.2014.0012","article-title":"Involvement of the janus kinase\/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis","volume":"34","author":"Benveniste","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.yexcr.2025.114769_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2022.100053","article-title":"Neural stem cell engineering for the treatment of multiple sclerosis","volume":"4","author":"Ahmed","year":"2022","journal-title":"Biomed. Eng. Adv."},{"key":"10.1016\/j.yexcr.2025.114769_bib99","article-title":"A threshold level of JNK activates damage-responsive enhancers via JAK\/STAT to promote tissue regeneration","author":"Quinn","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.yexcr.2025.114769_bib100","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211035542","article-title":"Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders","volume":"14","author":"Brummer","year":"2021","journal-title":"Therapeut. Adv. Neurol. Disorder."},{"key":"10.1016\/j.yexcr.2025.114769_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271102","article-title":"SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis","volume":"14","author":"Pandey","year":"2023","journal-title":"Front. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.yexcr.2025.114769_bib102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000507782","article-title":"Emerging treatment options in inflammatory bowel disease: janus kinases, stem cells, and more","volume":"101","author":"Misselwitz","year":"2020","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114769_bib103","article-title":"Pathogenesis and management of multiple sclerosis revisited, Disease-a-Month","volume":"69","author":"Shah","year":"2023"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib104","article-title":"Notch signaling and T\u2010helper cells in EAE\/MS","volume":"2013","author":"Bassil","year":"2013","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib105","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.1301116","article-title":"Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis","volume":"191","author":"Sandy","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570159X22666240731114906","article-title":"Notch signaling in central nervous system: from cellular development to multiple sclerosis disease","volume":"23","author":"Askari","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib107","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/eji.201646901","article-title":"Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming","volume":"47","author":"Fern\u00e1ndez","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2025.114769_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254586","article-title":"Astrogliosis in multiple sclerosis and neuro-inflammation: what role for the notch pathway?","volume":"14","author":"Mora","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib109","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1002\/jcb.27197","article-title":"Effect of Notch1 gene on remyelination in multiple sclerosis in mouse models of acute demyelination","volume":"119","author":"Fan","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00401-006-0170-9","article-title":"Notch1 and its ligand Jagged1 are present in remyelination in a T-cell-and antibody-mediated model of inflammatory demyelination","volume":"113","author":"Seifert","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib111","first-page":"10","article-title":"Revisiting Notch in remyelination of multiple sclerosis lesions","volume":"119","author":"Brosnan","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib112","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/jnc.12440","article-title":"The Notch signaling pathway: its role in focal CNS demyelination and apotransferrin\u2010induced remyelination","volume":"127","author":"Aparicio","year":"2013","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.yexcr.2025.114769_bib113","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.3390\/ijms23158077","article-title":"The mTOR signaling pathway in multiple sclerosis; from animal models to human data","volume":"23","author":"Vakrakou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.yexcr.2025.114769_bib114","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2025.114769_bib115","series-title":"mTOR Inhibitor-Corticoid Combination Therapy for Multiple Sclerosis","author":"Hoepner","year":"2018"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/glia.22433","article-title":"mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis","volume":"61","author":"Dello Russo","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib117","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40120-023-00455-y","article-title":"Genetically determined levels of mtor-dependent circulating proteins and risk of multiple sclerosis","volume":"12","author":"Zhang","year":"2023","journal-title":"Neurol. Therap."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib118","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib119","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1007\/s11033-023-08419-z","article-title":"Transforming growth factor \u03b2 (TGF-\u03b2) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches","volume":"50","author":"Esmaeilzadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/eji.201646716","article-title":"TGF\u2010\u03b2 regulation of encephalitogenic and regulatory T cells in multiple sclerosis","volume":"47","author":"Lee","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib121","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.4049\/jimmunol.164.6.3207","article-title":"TGF-\u03b22 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis","volume":"164","author":"Drescher","year":"2000","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib122","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib123","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","article-title":"TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer","volume":"22","author":"Giarratana","year":"2024","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13543776.2024.2346325","article-title":"Targeting the TGF-\u03b2 signaling pathway: an updated patent review (2021\u2013present)","volume":"34","author":"Guo","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1_Supplement","key":"10.1016\/j.yexcr.2025.114769_bib125","doi-asserted-by":"crossref","first-page":"170.12","DOI":"10.4049\/jimmunol.210.Supp.170.12","article-title":"miRNAs targeting TGF\u03b2-signaling disrupt Treg development and function in CNS autoimmunity","volume":"210","author":"Rau","year":"2023","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5114\/fn.2020.102433","article-title":"A link between promoter polymorphisms of the transforming growth factor \u03b21 (TGFB1) and TGF-\u03b21 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis","volume":"58","author":"Grigorova","year":"2020","journal-title":"Folia Neuropathol."},{"issue":"19","key":"10.1016\/j.yexcr.2025.114769_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914447","article-title":"Changes in the expression of TGF-beta regulatory pathway genes induced by vitamin D in patients with relapsing-remitting multiple sclerosis","volume":"24","author":"Lozano-Ros","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib128","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/glia.23033","article-title":"TGF\u03b2 regulates persistent neuroinflammation by controlling Th1 polarization and ROS production via monocyte\u2010derived dendritic cells","volume":"64","author":"Parsa","year":"2016","journal-title":"Glia"},{"issue":"23","key":"10.1016\/j.yexcr.2025.114769_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314993","article-title":"Irrespective of plaque activity, multiple sclerosis brain periplaques exhibit alterations of myelin genes and a TGF-beta signature","volume":"23","author":"Nataf","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib130","article-title":"Multifaceted roles of the E3 ubiquitin ligase RING finger protein 115 in immunity and diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.yexcr.2025.114769_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111638","article-title":"The importance of phosphoinositide 3-kinase in neuroinflammation","volume":"25","author":"Wright","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib132","article-title":"Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice","volume":"8","author":"Shang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib133","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1021\/acs.jmedchem.8b00085","article-title":"Design and synthesis of a novel series of orally bioavailable, CNS-penetrant, isoform selective phosphoinositide 3-kinase \u03b3 (PI3K\u03b3) inhibitors with potential for the treatment of multiple sclerosis (MS)","volume":"61","author":"Come","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yexcr.2025.114769_bib134","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3389\/fimmu.2019.01738","article-title":"Akt3-mediated protection against inflammatory demyelinating disease","volume":"10","author":"DuBois","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114769_bib135","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s13760-020-01518-9","article-title":"Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients","volume":"121","author":"Oktelik","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib136","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1080\/21655979.2022.2052671","article-title":"Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88\/PI3K\/Akt\/NF-\u03baB signalling pathway","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib137","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/acschemneuro.2c00653","article-title":"MAGI2-AS3 and miR-374b-5p as putative regulators of multiple sclerosis via modulating the PTEN\/AKT\/IRF-3\/IFN-\u03b2 Axis: new clinical insights","volume":"14","author":"Kortam","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib138","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1523\/JNEUROSCI.3316-16.2017","article-title":"Signaling by FGF receptor 2, not FGF receptor 1, regulates myelin thickness through activation of ERK1\/2\u2013MAPK, which promotes mTORC1 activity in an Akt-independent manner","volume":"37","author":"Furusho","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib139","series-title":"Growth Factor Signaling Pathways Converge on the TSC Complex to Control mTOR","author":"Ilagan","year":"2019"},{"key":"10.1016\/j.yexcr.2025.114769_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-11-3","article-title":"Platelet-derived growth factor-induced Akt phosphorylation requires mTOR\/Rictor and phospholipase C-\u03b31, whereas S6 phosphorylation depends on mTOR\/Raptor and phospholipase D","volume":"11","author":"Razmara","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexcr.2025.114769_bib141","series-title":"The Receptor Interacting Protein 1 Mediates a Link between NF\u03baB and PI3-Kinase Signaling","first-page":"2671","author":"Chauncey","year":"2009"},{"key":"10.1016\/j.yexcr.2025.114769_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739452","article-title":"Dual targeting by inhibition of phosphoinositide-3-Kinase and mammalian target of rapamycin attenuates the neuroinflammatory responses in murine hippocampal cells and seizures in C57BL\/6 mice","volume":"12","author":"Vyas","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114769_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02325-6","article-title":"Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation","volume":"18","author":"Chu","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib144","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/fnl.12.72","article-title":"A critical kinase cascade in neurological disorders: PI3K, Akt and mTOR","volume":"7","author":"Chong","year":"2012","journal-title":"Future Neurol."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib145","doi-asserted-by":"crossref","first-page":"e3090","DOI":"10.1038\/cddis.2017.490","article-title":"Neuron and microglia\/macrophage-derived FGF10 activate neuronal FGFR2\/PI3K\/Akt signaling and inhibit microglia\/macrophages TLR4\/NF-\u03baB-dependent neuroinflammation to improve functional recovery after spinal cord injury","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib146","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1523\/JNEUROSCI.2139-10.2011","article-title":"Spinal phosphinositide 3-Kinase\u2013Akt\u2013Mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia","volume":"31","author":"Xu","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib147","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1523\/JNEUROSCI.2255-17.2017","article-title":"Sustained MAPK\/ERK activation in adult Schwann cells impairs nerve repair","volume":"38","author":"Cervellini","year":"2018","journal-title":"J. Neurosci."},{"issue":"47","key":"10.1016\/j.yexcr.2025.114769_bib148","doi-asserted-by":"crossref","first-page":"18402","DOI":"10.1523\/JNEUROSCI.2381-13.2013","article-title":"Signaling through ERK1\/2 controls myelin thickness during myelin repair in the adult central nervous system","volume":"33","author":"Fyffe-Maricich","year":"2013","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib149","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/glia.23602","article-title":"Independent and cooperative roles of the Mek\/ERK1\/2\u2010MAPK and PI3K\/Akt\/mTOR pathways during developmental myelination and in adulthood","volume":"67","author":"Ishii","year":"2019","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib150","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/glia.23606","article-title":"Inhibition of MAPK\/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases","volume":"67","author":"Suo","year":"2019","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib151","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bpa.12916","article-title":"Oligodendrocyte\u2010specific deletion of FGFR2 ameliorates MOG35\u201055\u2010induced EAE through ERK and Akt signalling","volume":"31","author":"Kamali","year":"2021","journal-title":"Brain Pathol."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib152","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/glia.22838","article-title":"Fibroblast growth factor signaling in oligodendrocyte\u2010lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions","volume":"63","author":"Furusho","year":"2015","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib153","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191390","article-title":"Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis","volume":"217","author":"Cunha","year":"2020","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009380","article-title":"Myelin activates FAK\/Akt\/NF-\u03baB pathways and provokes CR3-dependent inflammatory response in murine system","volume":"5","author":"Sun","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib155","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.1913997117","article-title":"STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0116-1","article-title":"IKK\u03b2-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1\/Th17 cell activation and compromising blood brain barrier","volume":"11","author":"Lee","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036408","article-title":"Interferon-\u03b3 activates nuclear factor-\u03ba B in oligodendrocytes through a process mediated by the unfolded protein response","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib158","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.apsb.2023.07.026","article-title":"JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes","volume":"13","author":"Shao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib159","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/cells13121042","article-title":"A camelid-derived STAT-specific nanobody inhibits neuroinflammation and ameliorates experimental autoimmune encephalomyelitis (EAE)","volume":"13","author":"Mbanefo","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib160","article-title":"STAT3 activation in combination with NF\u2010kappaB inhibition induces tolerogenic dendritic cells with high therapeutic potential to attenuate collagen\u2010induced arthritis","volume":"2019","author":"Prado","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib161","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1172\/JCI92387","article-title":"Neural precursor cell\u2013secreted TGF-\u03b22 redirects inflammatory monocyte-derived cells in CNS autoimmunity","volume":"127","author":"De Feo","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"31","key":"10.1016\/j.yexcr.2025.114769_bib162","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1073\/pnas.0805058105","article-title":"TGF-\u03b2 signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis","volume":"105","author":"Laouar","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114769_bib163","doi-asserted-by":"crossref","DOI":"10.1242\/dev.204589","article-title":"Notch signaling in neurogenesis","volume":"152","author":"McLaren","year":"2025","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib164","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ydbio.2018.10.004","article-title":"Sequential specification of oligodendrocyte lineage cells by distinct levels of Hedgehog and Notch signaling","volume":"444","author":"Ravanelli","year":"2018","journal-title":"Dev. Biol."},{"key":"10.1016\/j.yexcr.2025.114769_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8104-6-20","article-title":"Prospero and Pax2 combinatorially control neural cell fate decisions by modulating Ras-and Notch-dependent signaling","volume":"6","author":"Charlton-Perkins","year":"2011","journal-title":"Neural Dev."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib166","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2671","article-title":"Stem cell mTOR signaling directs region-specific cell fate decisions during intestinal nutrient adaptation","volume":"10","author":"Mattila","year":"2024","journal-title":"Sci. Adv."},{"issue":"22","key":"10.1016\/j.yexcr.2025.114769_bib167","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1093\/bioinformatics\/btr551","article-title":"Neural fate decisions mediated by trans-activation and cis-inhibition in Notch signaling","volume":"27","author":"Wang","year":"2011","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib168","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1042\/BST20130046","article-title":"Akt\/mTOR signalling in myelination","volume":"41","author":"Norrm\u00e9n","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"25","key":"10.1016\/j.yexcr.2025.114769_bib169","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1105-14.2014","article-title":"Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination","volume":"34","author":"Lebrun-Julien","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29241","article-title":"Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system","volume":"6","author":"Figlia","year":"2017","journal-title":"eLife"},{"issue":"41","key":"10.1016\/j.yexcr.2025.114769_bib171","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1523\/JNEUROSCI.0783-21.2021","article-title":"The Akt-mTOR pathway drives myelin sheath growth by regulating cap-dependent translation","volume":"41","author":"Fedder-Semmes","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib172","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41869","article-title":"Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"eLife"},{"issue":"31","key":"10.1016\/j.yexcr.2025.114769_bib173","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1523\/JNEUROSCI.3454-16.2017","article-title":"Loss of tuberous sclerosis complex1 in adult oligodendrocyte progenitor cells enhances axon remyelination and increases myelin thickness after a focal demyelination","volume":"37","author":"McLane","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib174","series-title":"Manipulating Developmental Mechanisms to Promote Remyelination","author":"Harrington","year":"2012"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib175","doi-asserted-by":"crossref","DOI":"10.1111\/resp.13415","article-title":"TGF\u2010\u03b2: master regulator of inflammation and fibrosis","volume":"23","author":"Stewart","year":"2018","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib176","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12890-024-03050-5","article-title":"Sinomenine attenuates pulmonary fibrosis by downregulating TGF-\u03b21\/Smad3, PI3K\/Akt and NF-\u03baB signaling pathways","volume":"24","author":"Yao","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.yexcr.2025.114769_bib177","series-title":"Clinicopathological features in prostate cancer, The Aging Male","article-title":"TGF-\u03b2\/PI3K\/AKT\/mTOR\/NF-kB pathway","author":"Torrealba","year":"2020"},{"key":"10.1016\/j.yexcr.2025.114769_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00338","article-title":"Neurofilament light chain as a biomarker in multiple sclerosis","volume":"10","author":"Varhaug","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib179","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa188","article-title":"Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches","volume":"22","author":"Lee","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.yexcr.2025.114769_bib180","article-title":"Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.yexcr.2025.114769_bib181","doi-asserted-by":"crossref","DOI":"10.1177\/11772719211013352","article-title":"Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches","volume":"16","author":"Jafari","year":"2021","journal-title":"Biomark. Insights"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib182","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.3390\/ijms23115877","article-title":"Current and future biomarkers in multiple sclerosis","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib183","series-title":"Multiple Sclerosis: Pathogenesis Mechanism and Biomarkers, Central Nervous System Agents in Medicinal Chemistry","author":"Arya","year":"2024"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib184","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/br.2022.1579","article-title":"Multiple sclerosis and computational biology","volume":"17","author":"Diakou","year":"2022","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.yexcr.2025.114769_bib185","first-page":"9","article-title":"Biomarkers, drug treatment and experimental models of multiple sclerosis","volume":"23","author":"Jain","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.yexcr.2025.114769_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1076421","article-title":"Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis","volume":"14","author":"Lorefice","year":"2023","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib187","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae081","article-title":"Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease","volume":"6","author":"Meeker","year":"2024","journal-title":"Brain Commun."},{"issue":"19","key":"10.1016\/j.yexcr.2025.114769_bib188","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib189","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/pharmaceutics15041100","article-title":"Novel developments to enable treatment of CNS diseases with targeted drug delivery","volume":"15","author":"Meyer","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114769_bib190","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/ijms18071415","article-title":"Theranostic liposome\u2013nanoparticle hybrids for drug delivery and bioimaging","volume":"18","author":"\u015eeleci","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114769_bib191","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114769_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.721581","article-title":"Regulation of stem cell differentiation by inorganic nanomaterials: recent advances in regenerative medicine","volume":"9","author":"He","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114769_bib193","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018820","article-title":"The adult ventricular-subventricular zone (V-SVZ) and olfactory bulb (OB) neurogenesis","volume":"8","author":"Lim","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.yexcr.2025.114769_bib194","first-page":"1","article-title":"A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells","volume":"11","author":"Shroff","year":"2018","journal-title":"Stem Cells Cloning"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/mt.2013.241","article-title":"Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther.: J. Am. Soc. Gene Therapy"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib196","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13287-017-0716-x","article-title":"Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Res. Ther."},{"issue":"22","key":"10.1016\/j.yexcr.2025.114769_bib197","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.3390\/ijms21228662","article-title":"Mesenchymal stem cells in multiple sclerosis: recent evidence from pre-clinical to clinical studies","volume":"21","author":"Gugliandolo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114769_bib198","first-page":"5251313","article-title":"Roles of mesenchymal stem cells in spinal cord injury","volume":"2017","author":"Qu","year":"2017","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.yexcr.2025.114769_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711362","article-title":"The efficacy of mesenchymal stem cell therapies in rodent models of multiple sclerosis: an updated systematic review and meta-analysis","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib200","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/brain\/awaa333","article-title":"Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis","volume":"143","author":"Petrou","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yexcr.2025.114769_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2015.00257","article-title":"Remyelination therapy in multiple sclerosis","volume":"6","author":"Harlow","year":"2015","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15283\/ijsc19127","article-title":"Hematopoietic stem cells and their roles in tissue regeneration","volume":"13","author":"Lee","year":"2020","journal-title":"Int. J. Stem Cell."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-012-0162-5","article-title":"Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned","volume":"10","author":"Atkins","year":"2013","journal-title":"Neurotherapeutics: J. Am. Soc. Experiment. NeuroTherapeut."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib205","first-page":"200","article-title":"Directed differentiation of pluripotent stem cells by transcription factors","volume":"42","author":"Oh","year":"2019","journal-title":"Mol. Cells"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt292","article-title":"Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice","volume":"4","author":"Drury-Stewart","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2025.114769_bib207","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.progpolymsci.2015.02.004","article-title":"Advancing biomaterials of human origin for tissue engineering","volume":"53","author":"Chen","year":"2016","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1469-7580.2008.00878.x","article-title":"Tissue engineering: strategies, stem cells and scaffolds","volume":"213","author":"Howard","year":"2008","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib209","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/life11030231","article-title":"Interaction between neurons and the oligodendroglial lineage in multiple sclerosis and its preclinical models","volume":"11","author":"Pantazou","year":"2021","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/brainsci8060111","article-title":"Emerging cellular and molecular strategies for enhancing central nervous system (CNS) remyelination","volume":"8","author":"Abu-Rub","year":"2018","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062891","article-title":"The current challenges for drug discovery in CNS remyelination","volume":"22","author":"Balestri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib212","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911505","article-title":"Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem","volume":"12","author":"Griffin","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexcr.2025.114769_bib213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fneur.2015.00257","article-title":"Remyelination therapy in multiple sclerosis","volume":"6","author":"Harlow","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.yexcr.2025.114769_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.748849","article-title":"Novel in vitro experimental approaches to study myelination and remyelination in the central nervous system","volume":"15","author":"Marangon","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.yexcr.2025.114769_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fmats.2020.601795","article-title":"Trends in the development of tailored elastin-like recombinamer\u2013based porous biomaterials for soft and hard tissue applications","volume":"7","author":"Mbundi","year":"2021","journal-title":"Front. Mater."},{"key":"10.1016\/j.yexcr.2025.114769_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00225","article-title":"Central nervous system remyelination: roles of glia and innate immune cells","volume":"12","author":"Baaklini","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.yexcr.2025.114769_bib217","first-page":"372","article-title":"Biomaterial approaches to modulate reactive astroglial response, cells, tissues","volume":"205","author":"Zuidema","year":"2018","journal-title":"Organs"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib218","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1021\/acs.biomac.0c00045","article-title":"3D extracellular matrix mimics: fundamental concepts and role of materials chemistry to influence stem cell fate","volume":"21","author":"Nicolas","year":"2020","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114769_bib219","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008653","article-title":"Waking up quiescent neural stem cells: molecular mechanisms and implications in neurodevelopmental disorders","volume":"16","author":"Ding","year":"2020","journal-title":"PLoS Genet."},{"issue":"15","key":"10.1016\/j.yexcr.2025.114769_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153722","article-title":"A low molecular weight hyaluronic acid derivative accelerates excisional wound healing by modulating pro-inflammation, promoting epithelialization and neovascularization, and remodeling collagen","volume":"20","author":"Gao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib221","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/acn3.393","article-title":"PH20 is not expressed in murine CNS and oligodendrocyte precursor cells","volume":"4","author":"Marella","year":"2017","journal-title":"Annal. Clin. Translat. Neurol."},{"key":"10.1016\/j.yexcr.2025.114769_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000119","article-title":"Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures","volume":"1","author":"Gelain","year":"2006","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib223","article-title":"Electrospun fiber scaffolds for engineering glial cell behavior to promote neural regeneration","volume":"8","author":"Puhl","year":"2020","journal-title":"Bioengineering (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114769_bib224","article-title":"Multiple sclerosis: therapeutic frontiers and progressive disease","volume":"8","author":"Irani","year":"2008","journal-title":"Johns Hopkins Adv. Stud. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24009","article-title":"Multiple sclerosis: prospects and promise","volume":"74","author":"Hauser","year":"2013","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114769_bib226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/biomedicines7020026","article-title":"Stem cell-based therapies for multiple sclerosis: current perspectives","volume":"7","author":"Cuascut","year":"2019","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114769_bib227","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/cns.14176","article-title":"FGF\/FGFR system in the central nervous system demyelinating disease: recent progress and implications for multiple sclerosis","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.yexcr.2025.114769_bib228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114769_bib229","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1871527315666151110125840","article-title":"Molecular approach to targeted therapy for multiple sclerosis","volume":"15","author":"Sherbet","year":"2016","journal-title":"CNS Neurol. Disorder.-Drug Target.-CNS Neurol. Dis."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114769_bib230","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1177\/1352458517729455","article-title":"Targets of therapy in progressive MS","volume":"23","author":"Lassmann","year":"2017","journal-title":"Multiple Scleros. J."},{"issue":"9\u201310","key":"10.1016\/j.yexcr.2025.114769_bib231","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1017\/S1355617717000959","article-title":"Neuropsychology of multiple sclerosis: looking back and moving forward","volume":"23","author":"Benedict","year":"2017","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114769_bib232","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/WCO.0000000000000560","article-title":"Challenges and needs in experimental therapies for multiple sclerosis","volume":"31","author":"Lutterotti","year":"2018","journal-title":"Curr. Opin. Neurol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:33:31Z","timestamp":1780302811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":232,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0014482725003696"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114769","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism and the main signaling pathways in the development and progression of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114769"}}